Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
KALA
KALA BIO INC
$5.10MN/A0.00%N/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$12.35MN/A0.00%N/AN/AN/AN/A
SKYE
SKYE BIOSCIENCE INC
$28.15MN/A0.00%N/AN/AN/AN/A
BTAI
BIOXCEL THERAPEUTICS INC
$37.18MN/A0.00%N/AN/AN/AN/A
ACET
ADICET BIO INC
$84.48MN/A0.00%N/AN/AN/AN/A
CANF
CAN-FITE BIOPHARMA LTD
$2.62MN/AN/AN/AN/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$73.62MN/A0.00%N/AN/AN/AN/A
OSTX
OS THERAPIES INC
$47.19MN/A0.00%N/AN/AN/AN/A
ENLV
ENLIVEX THERAPEUTICS LTD
$18.34MN/A0.00%N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$76.96MN/A0.00%N/AN/AN/AN/A
RCKT
ROCKET PHARMACEUTICALS INC
$374.45MN/A0.00%N/AN/AN/AN/A
SGMO
SANGAMO THERAPEUTICS INC
$147.72MN/A0.00%N/AN/AN/AN/A
CODX
CO-DIAGNOSTICS INC
$11.29MN/A0.00%N/AN/AN/AN/A
LSTA
LISATA THERAPEUTICS INC
$17.29MN/A0.00%N/AN/AN/AN/A
TVRD
TVARDI THERAPEUTICS INC
$38.28MN/A0.00%N/AN/AN/AN/A
FEMY
FEMASYS INC
$37.25MN/A0.00%N/AN/AN/AN/A
AKTX
AKARI THERAPEUTICS PLC
$20.73MN/AN/AN/AN/AN/AN/A
NAKA
KINDLY MD INC
$179.46MN/A0.00%N/AN/AN/AN/A
IMUX
IMMUNIC INC
$70.13MN/A0.00%N/AN/AN/AN/A
PDSB
PDS BIOTECHNOLOGY CORP
$40.80MN/A0.00%N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$35.67MN/A0.00%N/AN/AN/AN/A
PMN
PROMIS NEUROSCIENCES INC
$15.37MN/A0.00%N/AN/AN/AN/A
VERU
VERU INC
$36.43MN/A0.00%N/AN/AN/AN/A
SNTI
SENTI BIOSCIENCES INC
$28.92MN/A0.00%N/AN/AN/AN/A
KRRO
KORRO BIO INC
$75.81MN/A0.00%N/AN/AN/AN/A
IFRX
INFLARX NV
$73.84MN/A0.00%N/AN/AN/AN/A
SLN
SILENCE THERAPEUTICS PLC
$290.20MN/AN/AN/AN/AN/AN/A
MSAI
MULTISENSOR AI HOLDINGS INC
$16.23MN/A0.00%N/AN/AN/AN/A
HUMA
HUMACYTE INC
$182.59MN/A0.00%N/AN/AN/AN/A
ONCY
ONCOLYTICS BIOTECH INC
$101.98MN/A0.00%N/AN/AN/AN/A
SXTP
60 DEGREES PHARMACEUTICALS INC
$2.18MN/A0.00%N/AN/AN/AN/A
CING
CINGULATE INC
$29.60MN/A0.00%N/AN/AN/AN/A
ATYR
ATYR PHARMA INC
$74.37MN/A0.00%N/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$33.52MN/A0.00%N/AN/AN/AN/A
CTSO
CYTOSORBENTS CORP
$41.20MN/A0.00%N/AN/AN/AN/A
ZSPC
ZSPACE INC
$14.93MN/A0.00%N/AN/AN/AN/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$16.95MN/A0.00%N/AN/AN/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$165.26MN/A0.00%N/AN/AN/AN/A
MYO
MYOMO INC
$38.05MN/A0.00%N/AN/AN/AN/A
PALI
PALISADE BIO INC
$372.51MN/A0.00%N/AN/AN/AN/A
TNYA
TENAYA THERAPEUTICS INC
$122.38MN/A0.00%N/AN/AN/AN/A
HOWL
WEREWOLF THERAPEUTICS INC
$31.31MN/A0.00%N/AN/AN/AN/A
MREO
MEREO BIOPHARMA GROUP PLC
$81.16MN/A0.00%N/AN/AN/AN/A
IBRX
IMMUNITYBIO INC
$1.99BN/A0.00%N/AN/AN/AN/A
CABA
CABALETTA BIO INC
$212.75MN/A0.00%N/AN/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$57.88MN/A0.00%N/AN/AN/AN/A
JSPR
JASPER THERAPEUTICS INC
$51.49MN/A0.00%N/AN/AN/AN/A
BMEA
BIOMEA FUSION INC
$94.74MN/A0.00%N/AN/AN/AN/A
RZLT
REZOLUTE INC
$200.76MN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.